Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Lymphoma 25Leukemia 20Lymphoma, Large B-Cell, Diffuse 19Lymphoma, Non-Hodgkin 15Neoplasms 14Lymphoma, Follicular 14Recurrence 10Myelodysplastic Syndromes 10Leukemia, Myeloid, Acute 10Hematologic Neoplasms 8Burkitt Lymphoma 8Leukemia, Lymphocytic, Chronic, B-Cell 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Hodgkin Disease 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms, Plasma Cell 5Neoplasms by Site 5Neoplasms by Histologic Type 5Multiple Myeloma 5Lymphoproliferative Disorders 5Lymphoma, Mantle-Cell 5Infections 5Graft vs Host Disease 5Lymphoma, B-Cell, Marginal Zone 4Lymphoma, B-Cell 4Leukemia, Biphenotypic, Acute 4Anemia, Refractory, with Excess of Blasts 4Lymphoma, T-Cell, Peripheral 3Leukemia, T-Cell 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Opportunistic Infections × Lymphoid × Clear all
NCT02942173 2023-03-16

CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 2/3 Completed
150 enrolled
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Opportunistic Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡